NIH-funded research R01 grant

Understanding how tuberculosis bacteria divide to develop new treatments

Official title: Membrane Protein Complexes in the M. Tuberculosis Divisome: Structures and Interactions

Funded at Florida State University · NIH-11130365 · Data updated 2026-11-12

This study is looking at how the bacteria that cause tuberculosis divide, with the goal of finding new treatments for drug-resistant tuberculosis, so patients can have better options for getting well.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida State University
NIH-funded
Lab location1 site (Tallahassee, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$721,194
NIH project number1R01AI185198-01A1
Project IDNIH-11130365 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with tuberculosis, especially those with multi-drug resistant strains.

Less likely to help

Patients with non-tuberculosis related conditions or those who do not have active tuberculosis may not benefit from this research.

What this research studies

This research focuses on the mechanisms of cell division in the tuberculosis-causing bacteria, Mycobacterium tuberculosis. By examining the structures and interactions of specific protein complexes involved in this process, the research aims to uncover new ways to combat drug-resistant tuberculosis. The approach involves detailed structural characterizations to identify how these proteins function differently from those in other bacteria, which could lead to the development of innovative therapies. Patients may benefit from new treatments that effectively target drug-resistant strains of tuberculosis.

Why it matters

Potential benefit: If successful, this research could lead to the development of new therapies for tuberculosis, particularly for drug-resistant cases.

How similar studies have gone: While research on tuberculosis has been ongoing, the specific approach of targeting the divisome's protein complexes for new drug development is relatively novel.

Where this research is happening

  • Florida State University
    Tallahassee, United States
    Active

Researchers

  • Principal investigator: Hu, Yan-Yan — Florida State University
  • Study coordinator: Hu, Yan-Yan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.